82 related articles for article (PubMed ID: 7518371)
1. In vitro efficacy of anti-glial fibrillary acidic protein monoclonal antibodies against human malignant glioma cell lines.
Abaza MS; Narayan RK; Atassi MZ
Jpn J Cancer Res; 1997 Nov; 88(11):1094-9. PubMed ID: 9439685
[TBL] [Abstract][Full Text] [Related]
2. BCAS1 defines a heterogeneous cell population in diffuse gliomas.
Morales-Gallel R; Ulloa-Navas MJ; García-Tárraga P; Prat-Acín R; Reynés G; Pérez-Borredá P; Rubio L; Capilla-González V; Ferrer-Lozano J; García-Verdugo JM
Oncotarget; 2024 Jan; 15():49-64. PubMed ID: 38275289
[TBL] [Abstract][Full Text] [Related]
3. Exploring Immunohistochemistry in Fish: Assessment of Antibody Reactivity by Western Immunoblotting.
Antuofermo E; Orioles M; Murgia C; Burrai GP; Penati M; Gottardi C; Polinas M; Volpatti D; Galeotti M; Addis MF
Animals (Basel); 2023 Sep; 13(18):. PubMed ID: 37760333
[TBL] [Abstract][Full Text] [Related]
4. Sleeping Beauty mouse models identify candidate genes involved in gliomagenesis.
Vyazunova I; Maklakova VI; Berman S; De I; Steffen MD; Hong W; Lincoln H; Morrissy AS; Taylor MD; Akagi K; Brennan CW; Rodriguez FJ; Collier LS
PLoS One; 2014; 9(11):e113489. PubMed ID: 25423036
[TBL] [Abstract][Full Text] [Related]
5. Flow Cytometry Identification of Cell Compartments in the Murine Brain.
Moffet JJD; Moore Z; Oliver SJ; Towers T; Jenkins MR; Freytag S; Whittle JR; Best SA
Methods Mol Biol; 2023; 2691():185-198. PubMed ID: 37355546
[TBL] [Abstract][Full Text] [Related]
6. Letter to the editor: Increase in serum vimentin levels in patients with glioma and its correlation with prognosis of patients with glioblastoma.
Shafique MA; Kumar A; Arsal SA
Neurosurg Rev; 2023 Sep; 46(1):237. PubMed ID: 37688641
[No Abstract] [Full Text] [Related]
7. CD15 Expression Does Not Identify a Phenotypically or Genetically Distinct Glioblastoma Population.
Kenney-Herbert E; Al-Mayhani T; Piccirillo SG; Fowler J; Spiteri I; Jones P; Watts C
Stem Cells Transl Med; 2015 Jul; 4(7):822-31. PubMed ID: 26019225
[TBL] [Abstract][Full Text] [Related]
8. Expression of cytokeratins in glioblastoma multiforme.
Terada T
Pathol Oncol Res; 2015 Jul; 21(3):817-9. PubMed ID: 25633990
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of neuronal marker expression in glioblastomas.
Lee KH; Kang KJ; Moon KS; Jung TY; Jung S; Kim JH; Kim HS; Lee MC
Childs Nerv Syst; 2012 Nov; 28(11):1879-86. PubMed ID: 22922887
[TBL] [Abstract][Full Text] [Related]
10. Secondary glioblastoma with advanced neuronal immunophenotype.
Shibahara J; Fukayama M
Virchows Arch; 2005 Sep; 447(3):665-8. PubMed ID: 15968544
[TBL] [Abstract][Full Text] [Related]
11. Intermediate filaments in the nervous system: implications in cancer.
Ho CL; Liem RK
Cancer Metastasis Rev; 1996 Dec; 15(4):483-97. PubMed ID: 9034605
[TBL] [Abstract][Full Text] [Related]
12. Expression of oligodendrocytic mRNAs in glial tumors: changes associated with tumor grade and extent of neoplastic infiltration.
Landry CF; Verity MA; Cherman L; Kashima T; Black K; Yates A; Campagnoni AT
Cancer Res; 1997 Sep; 57(18):4098-104. PubMed ID: 9307299
[TBL] [Abstract][Full Text] [Related]
13. [Immunohistochemical study of S-phase cells in human gliomas].
Ibayashi N; Hirakawa K; Suzuki K; Nakamura K; Houri T
No To Shinkei; 1988 Aug; 40(8):763-9. PubMed ID: 2460117
[TBL] [Abstract][Full Text] [Related]
14. Histopathology, classification, and grading of gliomas.
Kleihues P; Soylemezoglu F; Schäuble B; Scheithauer BW; Burger PC
Glia; 1995 Nov; 15(3):211-21. PubMed ID: 8586458
[TBL] [Abstract][Full Text] [Related]
15. Molecular pathways in the formation of gliomas.
von Deimling A; Louis DN; Wiestler OD
Glia; 1995 Nov; 15(3):328-38. PubMed ID: 8586467
[TBL] [Abstract][Full Text] [Related]
16. Expression of non-glial intermediate filament proteins in gliomas.
Hirato J; Nakazato Y; Ogawa A
Clin Neuropathol; 1994; 13(1):1-11. PubMed ID: 7518371
[TBL] [Abstract][Full Text] [Related]
17. Human glioma associated intermediate filament proteins: over-expression, co-localization and cross-reactivity.
Abaza MS; Shaban F; Narayan RK; Atassi MZ
Anticancer Res; 1998; 18(2B):1333-40. PubMed ID: 9615812
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
